Coloplast A/S (CLPBY) Projected to Post Earnings on Friday

Coloplast A/S (OTCMKTS:CLPBY) will likely be issuing its results before the market opens on Friday, February 6th. Analysts expect the company to announce earnings of $0.09 per share for the quarter.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.02). The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. Coloplast A/S had a net margin of 13.01% and a return on equity of 24.99%. On average, analysts expect Coloplast A/S to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Coloplast A/S Stock Performance

CLPBY stock opened at $8.60 on Friday. The firm has a market cap of $19.38 billion, a PE ratio of 35.83, a P/E/G ratio of 0.81 and a beta of 0.26. The business has a 50 day moving average of $8.74 and a 200-day moving average of $9.13. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 1.20. Coloplast A/S has a 12-month low of $8.34 and a 12-month high of $11.73.

Wall Street Analyst Weigh In

Separately, Sanford C. Bernstein upgraded Coloplast A/S to a “hold” rating in a report on Wednesday. Three analysts have rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.